Biggest Swings: MyMD Pharmaceuticals Inc. (MYMD:NAQ) among top 50 on Sept. 2

0Comments

MyMD Pharmaceuticals Inc. (MYMD:NAQ) saw one of the biggest daily changes on Wall Street, down 10.7 percent throughout the day.

It fell $0.4, placing it 38th among the top 50 biggest swings in Wall Street during the time frame.

Shares in MyMD Pharmaceuticals Inc. finished on Sept. 2 at $3.34.

MyMD Pharmaceuticals Inc. employs nine people and has reported -$16,470,000 USD in income.

Stock fluctuations are affected by several factors, from news about the company involved to global trade difficulties or successes.

Despite a tumultuous year with the COVID-19 pandemic, the US stock market overall remained strong in 2021.

Tony Despirito at investment firm BlackRock said “Overall, companies have beat analyst expectations on both earnings per share and revenue growth. But the latter has been particularly strong.”

Nothing in this article is to be assumed as financial advice.

Individual companies can have several different types of shares across many stock markets. It is possible for different types of shares to see different results on the market.

Top 50 biggest stock market swings on Sept. 2

Company Name Percentage Change Current Trading Price
Shanrong Biotechnology Corp. 53.3% $1.15
ShiftPixy Inc. -52.8% $13.6
W World Corp. -33.6% $2
Millennium Investment & Acquisition Company Inc. 31.6% $1
Neuroone Medical Technologies Corp. -26.7% $1.89
4 Less Group Inc. -26.3% $4.79
Pear Therapeutics Inc. 26% $2.13
Cannabics Pharmaceuticals Inc. 22.7% $4.6
Immune Therapeutics Inc. 22.4% $1.97
Fortium Holdings Corp. 21.9% $1.95
Liquidia Corp. 20.6% $5.86
CareCloud Inc. 19.8% $3.87
Wheeler Real Estate Investment Trust Inc. 16.9% $2.42
Miromatrix Medical Inc. 16.8% $4.46
IN8BIO, Inc. -16.6% $2.41
Wheeler Real Estate Investment Trust Inc. 16.4% $3.98
Calavo Growers Inc. -15.9% $35.09
RDE Inc. 15.4% $1.5
Aurora Innovation Inc. 15.2% $2.43
Houston American Energy Corp. 14.5% $4.66
Minerva Neurosciences Inc. -14.2% $9.22
Enservco Corp. 13.3% $1.7
Eyenovia Inc. -13.2% $1.77
Reviva Pharmaceuticals Holdings, Inc. 13.2% $2.66
Omeros Corp. 13% $4.51
Blue Apron Holdings Inc. 12.6% $5.7
Finch Therapeutics Group Inc. 12.4% $2.36
Smartsheet Inc. 12.4% $34.52
Pennsylvania Real Estate Investment Trust -12.1% $4.07
MamaMancini’s Holdings Inc. -11.8% $1.35
NanoViricides Inc. -11.7% $2.11
TScan Therapeutics Inc. 11.6% $3.18
New York City REIT Inc. 11.4% $3.43
Motus GI Holdings Inc. -11.3% $2.91
Ardelyx Inc. 11.2% $1.09
Axcella Health Inc. 11.1% $2.6
Weatherford International PLC 10.8% $29.44
MyMD Pharmaceuticals Inc. -10.7% $3.34
Purple Innovation Inc. 10.7% $3.11
Intellinetics Inc. -10.5% $3.76
Arcutis Biotherapeutics Inc. -10.3% $24.11
CECO Environmental Corp. -10.1% $8.9
Canterbury Park Holding Corp. 10.1% $24.22
RiceBran Technologies -10.1% $2.58
Surgery Partners Inc. 10% $26.62
Alpha Teknova Inc. -10% $4.14
Sportsmans Warehouse Holdings Inc. 9.8% $8.53
CareDx Inc. -9.7% $18.33
National Cinemedia Inc. -9.7% $1.12
CYNGN Inc. 9.6% $1.37


Related

dummy-img

Kweisi Mfume discusses Iran interview and gun safety funding in recent tweets

U.S. Congressman Kweisi Mfume shared updates between March 31 and April 2, including his interview with Rev.

Kweisi Mfume, U.S. Representative of Maryland's 7th Congressional District

Kweisi Mfume highlights community engagement and national issues in recent social media posts

Congressman Kweisi Mfume posted about community celebrations, youth development grants in Baltimore, and federal accountability on AI threats between March 23-26, 2026.

Kate Burgin, Director and CEO of The Walters Art Museum in Baltimore

Medieval Mindscapes exhibition opens at the Walters Art Museum through August 23

The Walters Art Museum has opened “Medieval Mindscapes,” showcasing rare medieval manuscripts that encouraged imaginative engagement with art. The exhibition runs through August 23 and highlights unique artifacts from the museum’s extensive collection.

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from Baltimore City Wire.